Literature DB >> 23081741

Reliability and validity of the Japanese version of the pelvic floor distress inventory-short form 20.

Mikako Yoshida1, Ryoko Murayama, Erika Ota, Maki Nakata, Shiro Kozuma, Yukio Homma.   

Abstract

INTRODUCTION AND HYPOTHESIS: The aim of this study was to translate the Pelvic Floor Distress Inventory-Short Form 20 (PFDI-20) into Japanese and test its reliability and validity among Japanese women.
METHODS: Fifty-nine women with and without pelvic floor disorders (age 55.8 ± 16.8 years, mean ± SD) completed the Japanese PFDI-20 (J-PFDI-20) questionnaire at baseline and 2 weeks later. Intraclass correlation coefficients (ICC) and the Bland and Altman method for test-retest reliability and Cronbach's alpha for internal consistency of the J-PFDI-20 were used. Scores of total and subscales were compared between women with and without pelvic floor disorders for known-groups validity. Spearman's correlation coefficients between the J-PFDI-20 and the severity of pelvic floor disorders and Urinary Incontinence Quality of Life Scale (I-QOL) were used for construct validity.
RESULTS: The PFDI-20 was successfully translated from English into Japanese with face validity through rigorous cross-cultural validation. Test-retest reliability of the J-PFDI-20 and three subscales was good to excellent (ICC=0.77-0.90). The Bland and Altman analysis showed that differences between the first and second scores of total J-PFDI-20 and its subscales were not significantly different from 0 and largely fell within the range of 0 ± 1.96 SD. Cronbach's alpha values were 0.52-0.83. Analysis of known-groups validity showed differences in scores of the J-PFDI-20 between women with and without pelvic floor disorders. Acceptable construct validity was found in J-PFDI-20 total and subscale scores with positive correlations to severity of pelvic floor disorders (ρ>0.35) and negative correlations to I-QOL (ρ<-0.39).
CONCLUSIONS: The results suggest that the J-PFDI-20 is a reliable and valid condition-specific quality of life instrument for women with pelvic floor disorders.

Entities:  

Mesh:

Year:  2012        PMID: 23081741     DOI: 10.1007/s00192-012-1962-1

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  20 in total

1.  Fecal Incontinence Quality of Life Scale: quality of life instrument for patients with fecal incontinence.

Authors:  T H Rockwood; J M Church; J W Fleshman; R L Kane; C Mavrantonis; A G Thorson; S D Wexner; D Bliss; A C Lowry
Journal:  Dis Colon Rectum       Date:  2000-01       Impact factor: 4.585

2.  Core lower urinary tract symptom score (CLSS) for the assessment of female lower urinary tract symptoms: a comparative study.

Authors:  Tetsuya Fujimura; Haruki Kume; Yuzuri Tsurumaki; Yasukuni Yoshimura; Chihiro Hosoda; Motofumi Suzuki; Hiroshi Fukuhara; Yutaka Enomoto; Hiroaki Nishimatsu; Yukio Homma
Journal:  Int J Urol       Date:  2011-09-23       Impact factor: 3.369

3.  Validation of the Swedish short forms of the Pelvic Floor Impact Questionnaire (PFIQ-7), Pelvic Floor Distress Inventory (PFDI-20) and Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12).

Authors:  Pia Teleman; Karin Stenzelius; Linda Iorizzo; Ulf Jakobsson
Journal:  Acta Obstet Gynecol Scand       Date:  2011-05       Impact factor: 3.636

4.  Chinese validation of Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire.

Authors:  Symphorosa Shing Chee Chan; Rachel Yau Kar Cheung; Alice Ka Wah Yiu; Jimmy Chak Man Li; Beatrice Pui Yee Lai; Kwong Wai Choy; Tony Kwok Hung Chung
Journal:  Int Urogynecol J       Date:  2011-05-25       Impact factor: 2.894

5.  Further validation of the short form versions of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ).

Authors:  Matthew D Barber; Zhen Chen; Emily Lukacz; Alayne Markland; Clifford Wai; Linda Brubaker; Ingrid Nygaard; Alison Weidner; Nancy K Janz; Cathie Spino
Journal:  Neurourol Urodyn       Date:  2011-02-22       Impact factor: 2.696

6.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

7.  Is pelvic pain associated with defecatory symptoms in women with pelvic organ prolapse?

Authors:  Tirsit S Asfaw; Emily K Saks; Gina M Northington; Lily A Arya
Journal:  Neurourol Urodyn       Date:  2011-03-10       Impact factor: 2.696

8.  Quality of life of women with urinary incontinence: further development of the incontinence quality of life instrument (I-QOL)

Authors:  D L Patrick; M L Martin; D M Bushnell; I Yalcin; T H Wagner; D P Buesching
Journal:  Urology       Date:  1999-01       Impact factor: 2.649

9.  [Development of a linguistically validated French version of two short-form, condition-specific quality of life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7)].

Authors:  R de Tayrac; B Deval; H Fernandez; P Marès
Journal:  J Gynecol Obstet Biol Reprod (Paris)       Date:  2007-09-18

10.  Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program in Women (CPW) Research Group.

Authors:  S A Shumaker; J F Wyman; J S Uebersax; D McClish; J A Fantl
Journal:  Qual Life Res       Date:  1994-10       Impact factor: 4.147

View more
  8 in total

1.  Validation of the Chinese version of the Pelvic Floor Distress Inventory-20 (PFDI-20) according to the COSMIN checklist.

Authors:  Yidi Ma; Tao Xu; Ye Zhang; Meng Mao; Jia Kang; Lan Zhu
Journal:  Int Urogynecol J       Date:  2019-02-04       Impact factor: 2.894

2.  Validation of the Pelvic Floor Distress Inventory (PFDI-20) and Pelvic Floor Impact Questionnaire (PFIQ-7) in a Dutch population.

Authors:  Elaine Utomo; Bertil F Blok; Anneke B Steensma; Ida J Korfage
Journal:  Int Urogynecol J       Date:  2014-01-21       Impact factor: 2.894

3.  Validation of the PFDI-20 and PFIQ-7 quality of life questionnaires in two African languages.

Authors:  Etienne W Henn; Barry W Richter; Masekhoko M P Marokane
Journal:  Int Urogynecol J       Date:  2017-04-04       Impact factor: 2.894

4.  Thai translation and validation of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire, IUGA-Revised (PISQ-IR) and Pelvic Floor Distress Inventory (PFDI-20).

Authors:  Suvit Bunyavejchevin; Purim Ruanphoo
Journal:  Int Urogynecol J       Date:  2022-04-07       Impact factor: 1.932

5.  Clinical and urodynamic assessment in patients with pelvic organ prolapse before and after laparoscopic sacrocolpopexy.

Authors:  Bahiyah Abdullah; Jimmy Nomura; Shingo Moriyama; Tingwen Huang; Shino Tokiwa; Mio Togo
Journal:  Int Urogynecol J       Date:  2017-03-10       Impact factor: 2.894

6.  Validation of the short forms of the Pelvic Floor Distress Inventory (PFDI-20), Pelvic Floor Impact Questionnaire (PFIQ-7), and Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12) in Finnish.

Authors:  Nina Kristiina Mattsson; Kari Nieminen; Anna-Mari Heikkinen; Jyrki Jalkanen; Sari Koivurova; Marja-Liisa Eloranta; Pia Suvitie; Anna-Maija Tolppanen
Journal:  Health Qual Life Outcomes       Date:  2017-05-02       Impact factor: 3.186

Review 7.  Questionnaires to evaluate pelvic floor dysfunction in the postpartum period: a systematic review.

Authors:  Lea Tami Suzuki Zuchelo; Italla Maria Pinheiro Bezerra; Adna Thaysa Marcial Da Silva; Jéssica Menezes Gomes; José Maria Soares Júnior; Edmund Chada Baracat; Luiz Carlos de Abreu; Isabel Cristina Esposito Sorpreso
Journal:  Int J Womens Health       Date:  2018-08-08

8.  Postural Sensorimotor Control on Anorectal Pressures and Pelvic Floor Muscle Tone and Strength: Effects of a Single 5P® LOGSURF Session. A Cross-Sectional Preliminary Study.

Authors:  Laura Fuentes-Aparicio; Beatriz Arranz-Martín; Beatriz Navarro-Brazález; Javier Bailón-Cerezo; Beatriz Sánchez-Sánchez; María Torres-Lacomba
Journal:  Int J Environ Res Public Health       Date:  2021-04-02       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.